• Home
  • About Us
    • About Us
    • Subscribe
    • Privacy Policy
  • Advertise
    • Advertise On IP Watch
    • Editorial Calendar
  • Videos
  • Links
  • Help

Intellectual Property Watch

Original news and analysis on international IP policy

  • Copyright
  • Patents
  • Trademarks
  • Opinions
  • People News
  • Venues
    • Bilateral/Regional Negotiations
    • ITU/ICANN
    • United Nations – other
    • WHO
    • WIPO
    • WTO/TRIPS
    • Africa
    • Asia/Pacific
    • Europe
    • Latin America/Caribbean
    • North America
  • Themes
    • Access to Knowledge/ Open Innovation & Science
    • Food Security/ Agriculture/ Genetic Resources
    • Finance
    • Health & IP
    • Human Rights
    • Internet Governance/ Digital Economy/ Cyberspace
    • Lobbying
    • Technical Cooperation/ Technology Transfer
  • Health Policy Watch

No Agreement On Public Health At TRIPS Council

25/10/2005 by William New, Intellectual Property Watch Leave a Comment

Officials at the World Trade Organization committee responsible for intellectual property issues on Tuesday could not agree on how to permanently change trade law to permit poor countries in need to import drugs made elsewhere under compulsory license. The WTO Council on the Agreement on Trade-Related Aspects of Intellectual Property Rights (TRIPS) is under mandate […]

Filed Under: English, Health & IP, WTO/TRIPS

Indian Industry Pushing for Compulsory Licenses for Tamiflu

25/10/2005 by Tove Iren S. Gerhardsen for Intellectual Property Watch Leave a Comment

While Swiss-based Roche, the rights holder to the most-favoured medicine for avian influenza, is pursuing sub-licenses, India is moving ahead with exploring the option of compulsory licensing. If this goes through, India would be able to export Tamiflu to developing countries and certain developed countries. The Indian Cabinet is considering issuing compulsory licenses to local […]

Filed Under: Venues, Asia/Pacific, English, Health & IP, Patents/Designs/Trade Secrets, Regional Policy, WTO/TRIPS

Roche Seeks Deals On Bird Flu Drug As Compulsory Licenses Loom

20/10/2005 by Tove Iren S. Gerhardsen for Intellectual Property Watch 1 Comment

Roche, the Swiss-based company with rights to a medicine believed to be the most effective in the event of an avian influenza pandemic, has expressed openness to discussing arrangements with companies or governments to produce more of its flu treatment known as Tamiflu. But sceptics argue that the offer, made on 18 October, is too […]

Filed Under: English, Health & IP, Patents/Designs/Trade Secrets, WHO, WTO/TRIPS

IP Critical As Rocky US-Andean Trade Talks Resume

17/10/2005 by Martin Vaughan for Intellectual Property Watch Leave a Comment

By Martin Vaughan for Intellectual Property Watch Washington, DC—With negotiators set to resume work this week, Colombia, Peru and Ecuador are resisting demands by the United States for patent protections that go beyond those enshrined in international trade law in talks toward a U.S.-Andean free trade agreement continuing this fall. At the international level, trade-related […]

Filed Under: Bilateral/Regional Negotiations, English, Health & IP, Patents/Designs/Trade Secrets

Push For IP Deals Continues In Lead-Up To WTO Ministerial

09/08/2005 by William New, Intellectual Property Watch Leave a Comment

Issues under negotiation at the World Trade Organization committee responsible for intellectual property issues are somewhat stalled, despite – or because of – their ties to broader issues being negotiated at the WTO, sources in Geneva say. It remains to be seen which, if any, intellectual property-related issues end up being negotiated at the December […]

Filed Under: Biodiversity/Genetic Resources/Biotech, English, Health & IP, Trademarks/Geographical Indications/Domains, WTO/TRIPS

Health Experts Debate Solutions For New Treatments, Access To Medicines

08/06/2005 by William New, Intellectual Property Watch 1 Comment

Experts from across the political and socioeconomic spectrum spent three days last week at the World Health Organisation engaged in debate about the best ways to stimulate the development of new treatments for underserved illnesses and to improve poor countries’ access to available medicines. The task of summarizing the results of the meeting and other […]

Filed Under: Health & IP, United Nations - other, WHO

Medical R&D Treaty Debated At World Health Assembly

30/05/2005 by William New, Intellectual Property Watch Leave a Comment

Experts attending the U.N. World Health Assembly this month debated a proposal to create an international treaty on medical research and development aimed at making medical treatment affordable globally while ensuring continuing innovation in the area. The proposed treaty was created in consultation with a variety of non-governmental and government experts, and in February, 162 […]

Filed Under: English, Health & IP, Patents/Designs/Trade Secrets, United Nations - other, WHO

WHO Board Delays Decision On Trade-Related Proposal

27/05/2005 by William New, Intellectual Property Watch Leave a Comment

The World Health Organisation Executive Board on Friday postponed to January a proposal urging governments to adopt national policies on international trade and health. The draft resolution led by Thailand had the support of Benin, Bhutan, Bolivia, Brazil, Canada, China, Iraq, Jamaica, Kenya, Nepal, Sudan, Thailand, Tonga, Viet Nam, and others, but the board put […]

Filed Under: English, Health & IP, United Nations - other, WHO

Health Assembly Officials Watch For Last-Minute Amendments

20/05/2005 by William New, Intellectual Property Watch Leave a Comment

At the U.N. World Health Assembly negotiations in Geneva, officials have been watching carefully for the last-minute introduction of any amendments they view as unfavourable. This is true for all of the texts being developed, only some of which have a direct relation to intellectual property issues. The assembly, which runs from 16 to 25 […]

Filed Under: English, Health & IP, United Nations - other, WHO

Experts Discuss Essential Drugs Patent Pool Proposal

19/05/2005 by William New, Intellectual Property Watch Leave a Comment

Consumer representatives, United Nations diplomats, drug industry representatives and others this week discussed a proposal to form a patent pool for essential medicines. The proposal was put forward by Consumers International and the Consumer Project on Technology (CP Tech) at the annual U.N. World Health Assembly, and on Tuesday filled a room with people holding […]

Filed Under: English, Health & IP, Patents/Designs/Trade Secrets, United Nations - other

  • « Previous Page
  • 1
  • …
  • 196
  • 197
  • 198
  • 199
  • Next Page »
  • Email
  • Facebook
  • LinkedIn
  • RSS
  • Twitter
  • Vimeo
My Tweets

IPW News Briefs

Saudis Seek Alternative Energy Partners Through WIPO Green Program

Chinese IP Officials Complete Study Of UK, European IP Law

Perspectives on the US

In US, No Remedies For Growing IP Infringements

US IP Law – Big Developments On The Horizon In 2019

More perspectives on the US...

Supported Series: Civil Society And TRIPS Flexibilities

Civil Society And TRIPS Flexibilities Series – Translations Now Available

The Myth Of IP Incentives For All Nations – Q&A With Carlos Correa

Read the TRIPS flexibilities series...

Paid Content

Interview With Peter Vanderheyden, CEO Of Article One Partners

More paid content...

IP Delegates in Geneva

  • IP Delegates in Geneva
  • Guide to Geneva-based Public Health and IP Organisations

All Story Categories

Other Languages

  • Français
  • Español
  • 中文
  • اللغة العربية

Archives

  • Archives
  • Monthly Reporter

Staff Access

  • Writers

Sign up for free news alerts

This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy

Copyright © 2025 · Global Policy Reporting